The Quiet Crisis of Vitamin B12: A Wake-Up Call for Ageing Brains

A recent study from the University of California - San Francisco has highlighted a potentially insidious threat to older adults’ brain health. For decades, scientists have accepted that meeting the minimum vitamin B12 threshold is enough to safeguard brains against cognitive decline. However, this comforting narrative may be nothing more than a myth.

Researchers published their findings in Annals of Neurology, focusing on 231 healthy participants with an average age of 71. These individuals had B12 levels well above the US minimum cutoff of 148 pmol/L. Yet, when the researchers examined the biologically active form of the vitamin, they discovered a disturbing correlation: lower active B12 was linked to slower thinking, delayed visual processing, and more damage to the brain’s white matter.

The study’s lead author, Ari J. Green, notes that previous research may have overlooked subtle functional changes in the nervous system, leading to an incomplete picture of what constitutes optimal B12 levels. This insight raises questions about our current definition of deficiency and its implications for brain health.

Older adults are particularly vulnerable to low B12 because their bodies struggle to absorb this essential nutrient with age. Certain medications, digestive conditions, and diets can exacerbate the problem. This has significant implications for public health, as low but technically normal B12 levels may be more widespread than we think.

Other recent research has shed light on the complexities of B12 insufficiency. A 2025 review concluded that this deficiency remains a modifiable risk factor for neurological and cognitive problems, particularly in high-risk groups like older adults. Meanwhile, a 2025 systematic review found that supplementation with B vitamins produced only a small benefit in global cognitive function among older adults.

These findings paint a nuanced picture of the relationship between vitamin B12 and brain health. Rather than offering simple answers or panaceas, they underscore the need for a more comprehensive understanding of B12’s role in ageing brains. It is essential to consider not just the quantity of B12 but also its bioactive form. This might involve revisiting our current guidelines and exploring new biomarkers to detect problems earlier.

The implications are far-reaching: if low but normal B12 levels can silently impair thinking and memory, how many older adults may be unwittingly suffering from suboptimal brain function? As we strive for a better understanding of this complex issue, it is essential to prioritize research into the underlying biology of B12 insufficiency. By doing so, we might uncover new avenues for prevention and intervention – and spare countless brains the ravages of premature decline.

Ultimately, this study serves as a stark reminder that even within what appears to be a safe range, there can lie hidden dangers. As we age, our brains are vulnerable to various threats; it is time to give B12 insufficiency its due attention. The consequences of inaction will be dire: an ageing population with increasingly fragile minds and bodies.